Skip to Content
Skip to Content

Ainete hindamine - ühenduse hindamisplaan

Ainete hindamine - ühenduse hindamisplaan

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 26 november 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
205-491-7
141-62-8
2015
Norway
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Follow-up
Details
DCHP
201-545-9
84-61-7
2017
Sweden
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Information requested
Details
210-871-0
624-92-0
2014
Germany
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
231-673-0
7681-57-4
2014
Hungary
Suspected CMR
Exposure of environment
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
205-492-2
141-63-9
2015
Norway
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
609-946-4
41637-38-1
2021
Germany
Suspected PBT/vPvB
Exposure of environment
Not started
Details
404-740-9
115895-09-5
2016
Slovenia
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
272-902-4
68919-76-6
2021
Germany
Suspected PBT/vPvB
Exposure of environment
Not started
Details
701-057-0
-
2020
Germany
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Not started
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Follow-up
Details
249-535-3
29253-36-9
2020
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
629-767-5
1228186-18-2
2021
Germany
Exposure of environment
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
220-260-0
2691-41-0
2020
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Not started
Details
204-500-1
121-82-4
2020
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
271-867-2
68610-51-5
2016
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
-
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
468-710-7
754-12-1
2012
Germany
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
444-340-1
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
295-835-2
92129-33-4
2015
Italy
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
264-120-7
63393-96-4
2017
Italy
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Information requested
Details
EC No. 415-490-5 and 604-250-7
-
-
2016
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
915-730-3
-
2017
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Ongoing
Details
473-390-7
-
2016
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
906-484-8
-
2015
Slovenia
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
430-050-2
-
2017
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Follow-up
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Ongoing
Details
203-929-1
112-03-8
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
246-677-8
25155-23-1
2014
Italy
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Suspected PBT/vPvB
Wide dispersive use
Follow-up
Details
204-881-4
128-37-0
2016
France
Potential endocrine disruptor
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
258-469-4
53306-54-0
2020
Germany
Potential endocrine disruptor
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Not started
Details
629-732-4
1224966-13-5
2015
Lithuania
Sensitiser
Exposure of sensitive populations
Exposure of workers
Concluded
Details
220-449-8
2768-02-7
2013
Sweden
Suspected Sensitiser
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Follow-up
Details
202-773-1
99-62-7
2020
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
202-826-9
100-18-5
2020
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
222-429-4
3468-63-1
2019
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Ongoing
Details
249-820-2
29736-75-2
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
Ongoing
Details
239-701-3
15625-89-5
2014
France
Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
202-627-7
98-01-1
2021
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
221-975-0
3302-10-1
2020
Spain
Suspected Reprotoxic
Exposure of workers
Not started
Details
203-680-9
109-55-7
2014
Austria
Sensitiser
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
264-727-7
64194-22-5
2021
Slovenia
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Not started
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
219-207-4
2386-87-0
2013
Ireland
Suspected CMR
Sensitiser
Exposure of workers
High RCR
Concluded
Details
247-118-0
25584-83-2
2021
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
231-208-1
7446-70-0
2015
France
Suspected CMR
Exposure of workers
High (aggregated) tonnage
High RCR
Information requested
Details
232-235-1
7790-98-9
2015
Germany
Suspected Carcinogenic
Potential endocrine disruptor
Other hazard based concern
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
231-146-5
7440-36-0
2018
Germany
Suspected Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
215-713-4
1345-04-6
2018
Germany
Suspected Carcinogenic
Exposure of workers
High RCR
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
225-935-3
5160-02-1
2020
Germany
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Not started
Details
202-859-9
100-51-6
2016
Germany
Suspected Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Follow-up
Details
237-695-7
13927-71-4
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Not started
Details
243-001-3
19372-44-2
2015
Germany
Sensitiser
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Ongoing
Details
203-631-1
108-94-1
2016
Poland
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
234-042-8
10508-09-5
2015
Italy
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
Wide dispersive use
Follow-up
Details
246-835-6
25321-09-9
2020
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
214-189-4
1112-39-6
2020
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Not started
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Not started
Details
278-355-8
75980-60-8
2020
Sweden
Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of workers
Wide dispersive use
Not started
Details
203-584-7
108-45-2
2018
Latvia
Suspected Reprotoxic
Sensitiser
Exposure of workers
High (aggregated) tonnage
Concluded
Details
201-202-3
79-39-0
2016
Sweden
Other hazard based concern
Exposure of workers
Information requested
Details
202-049-5
91-20-3
2016
United Kingdom
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Concluded
Details
204-857-3
127-68-4
2020
Ireland
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Not started
Details
231-836-6
7758-19-2
2019
Hungary
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
Wide dispersive use
Ongoing
Details
205-739-4
149-44-0
2021
Netherlands
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
231-511-9
7601-89-0
2015
Germany
Suspected Carcinogenic
Potential endocrine disruptor
Other hazard based concern
Exposure of workers
Wide dispersive use
Concluded
Details
284-366-9
84852-53-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
244-617-5
21850-44-2
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
213-668-5
999-97-3
2014
Spain
High (aggregated) tonnage
High RCR
Concluded
Details
271-082-5
68515-40-2
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Information requested
Details
700-989-5
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Ongoing
Details
271-089-3
68515-47-9
2014
Denmark
High (aggregated) tonnage
Other exposure/risk based concern
Suspected CMR
Ongoing
Details
271-085-1
68515-43-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Ongoing
Details
202-425-9
95-50-1
2013
Hungary
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
627-083-1
244235-47-0
2015
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 216-133-4 | CAS no: 1506-02-1
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 244-240-6 | CAS no: 21145-77-7
-
-
2020
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Not started
Details
203-868-0
111-42-2
2012
Germany
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
203-312-7
105-59-9
2013
United Kingdom
Suspected CMR
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
205-483-3
141-43-5
2014
United Kingdom
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
253-781-7
38103-06-9
2013
Germany
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
1 - 4.5 moles propoxylated
500-097-4
37353-75-6
2013
Denmark
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
202-679-0
98-54-4
2014
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
246-678-3
25155-25-3
2015
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
287-477-0
85535-85-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
215-477-2
1327-41-9
2015
France
Suspected CMR
High (aggregated) tonnage
Information requested
Details
217-175-6
1762-95-4
2015
Czech Republic
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
810-801-4
-
2015
Netherlands
Suspected CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
202-163-5
92-52-4
2013
Portugal
Suspected PBT/vPvB
High (aggregated) tonnage
Conclusion under preparation
Details
201-247-9
80-07-9
2019
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
254-052-6
38640-62-9
2013
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
253-249-4
36878-20-3
2020
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Not started
Details
205-480-7
141-32-2
2013
Sweden
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Conclusion under preparation
Details
215-160-9
1308-38-9
2019
France
Suspected Reprotoxic
Suspected Sensitiser
High (aggregated) tonnage
Ongoing
Details
202-046-9
91-17-8
2012
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
203-956-9
112-30-1
2012
Italy
Other hazard based concern
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details

Export search results to:

Categories Display

Märgistatud:

(sisu otsimiseks klõpsake sildil)


Route: .live2